Pharma News

The FDA has approved an adeno-associated virus vector-based gene therapy to treat both adult and pediatric patients with aromatic L-amino acid decarboxylase deficiency.

Pfizer explores sale of hospital drugs unit amid activist investor’s call for accountability: Reuters

Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V

With high hopes for the economy, AstraZeneca adds $2B to US investment in manufacturing, R&D

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & Johnson‘s (J&J) nipocalimab for treating individuals with...

Preclinical + International Congress for Ataxia Research

FDA Takes Step Toward Removal of Ineffective Decongestants From the Market

Eisai lowers Leqembi revenue forecast after rocky entry to market

Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment

VitalityXtra may be harmful due to hidden drug ingredient

Lupin Secures Tentative U.S. FDA Approval For Generic HIV Drug Raltegravir

Werewolf Therapeutics, Inc., an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treat...